Vir Biotechnology, Inc. (VIR) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $765.28M | -33.5% |
| 2024 | $1.15B | -27.7% |
| 2023 | $1.59B | -23.5% |
| 2022 | $2.08B | +45.1% |
| 2021 | $1.43B | +99.7% |
| 2020 | $716.85M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $765.28M | -33.5% |
| 2024 | $1.15B | -27.7% |
| 2023 | $1.59B | -23.5% |
| 2022 | $2.08B | +45.1% |
| 2021 | $1.43B | +99.7% |
| 2020 | $716.85M | — |